In-Vitro Lung Model Market Forecast and Growth 2031

The In-Vitro Lung ModelMarket was valued at US$ 405.4 million in 2021 and is expected to reach US$ 1,194.4 million by 2031. The market is expected to register a CAGR of 12.0% from 2023–2031. Growing uptake of technologically advanced models is likely to remain key In-Vitro Lung Model Market trends.

In-Vitro Lung ModelMarket Analysis

Rising Respiratory Disorders

Chronic respiratory diseases (CRDs) are the leading cause of death and disability worldwide. CRDs include chronic obstructive pulmonary disease (COPD), asthma, and other chronic respiratory diseases such as occupational lung diseases and pulmonary hypertension. According to the Pan American Health Organization (PAHO) and World Health Organization (WHO) statistics, CRDs accounted for 8.9 million Years of Lives Lost (YLLs) of both sexes, among which 4.7 million were men and 4.2 million were women. Therefore, to control mortality rate of CRDs, there is an accelerated demand for in-vitro lung models to assess CRDs and design line of treatment (therapeutics). For example, a 3D model of the human respiratory tract (HRT) provides relevant information that can be used for studies aiming at better understanding lung biology, cross-talk between immune cells, airborne allergens and pathogens, and respiratory drug delivery. Such innovative 3D in-vitro lung models will try to improve treatment response towards CRDs among the population, driving market growth during 2021-2031.

In-Vitro Lung ModelMarket Overview

Technology, innovation, and smart technological solutions such as continue to influence In-Vitro Lung Model Market significantly. Rising respiratory disorders and management drugs and in-vitro lung model for lung fibrosisare the most influential factors responsible for In-Vitro Lung Model Market growth. Technologically advanced in-vitro lung model is a key trend for In-Vitro Lung Model Market growth. Engineered in-vitro lung models will provide lucrative market opportunity  for the In-Vitro Lung Model Market growth.

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Get FREE CUSTOMIZATION

In-Vitro Lung Model Market: Strategic Insights

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

In-Vitro Lung ModelMarket Drivers and Opportunities

In-Vitro Lung Model For Lung Fibrosis to Favor Market

In-vivo lung models prove valuable as they identify specific cellular and molecular mechanisms that can trigger pulmonary disease and progression. For example, in-vitro models are not only accessible for studying the molecular mechanisms targeting pulmonary fibrosis but also for innovative drug applications for screening fibrosis. The most frequently used in-vitro models to study pulmonary fibrosis are 2D cell cultures. Currently, in-vitro lung models have been developed to improve preclinical drug testing and bridge the translational gap to human clinical trials as these techniques offer advanced imaging and analysis of disease mechanisms, allowing drug discovery for validation and personalized treatment. Therefore, innovative models and applications of in-vitro lung models will assist to develop effective treatment options to treat pulmonary fibrosis thereby dominating market growth.

Engineered In-Vitro Lung Models– An Opportunity

The development of engineered in-vitro lung models is still a growing research field. However, there are some physiologically relevant engineered human in-vitro models. These include 3D-tissue-engineered lung models to study the immune response following viral infections of the small airway. The 3D in-vitro lung model is a promising research field to study lower respiratory viruses. Also, such 3D in-vitro lung models can be more predictive in studying viral pathogenesis, treatment strategies, and utility experimental analysis or therapeutic clinical trials. Therefore, such innovative 3D in-vitro lung model will provide lucrative market opportunities will account considerable market share in the coming years for in-vitro lung model market.

In-Vitro Lung Model

Market Report Segmentation Analysis

Key segments that contributed to the derivation of the In-Vitro Lung Model Market analysis are candidature and services.

• Based on Type, the In-Vitro Lung Model Market is divided into 2D and 3D. The 3D segment may hold a larger market share in 2023.
• Based on Application, the In-Vitro Lung Model Market is segmented as drug screening, toxicology, 3d model development, physiological research, stem cell research, and regenerative medicine. The drug screening segment may hold a larger market share in 2023.

In-Vitro Lung Model Market Share Analysis by Geography

The geographic scope of the In-Vitro Lung ModelMarket report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South America/South & Central America.

North America has dominated the In-Vitro Lung Model Market. In North America, US accounts considerable share for in-vitro lung model. Presence of top manufacturers present in the US, is one of the most influential factors responsible for market growth. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.  

In-Vitro Lung Model

Market Report Scope

In-Vitro Lung Model Market Regional Insights

The regional trends and factors influencing the In-Vitro Lung Model Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses In-Vitro Lung Model Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

In-Vitro Lung Model Market Report Scope

Market Players Density: Understanding Its Impact on Business Dynamics

The In-Vitro Lung Model Market market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the In-Vitro Lung Model Market are:

1. Epithelix Sarl
2. MATTEK
3. Lonza
4. Insphero
5. Emulate, Inc.
6. AlveoliX AG

Disclaimer: The companies listed above are not ranked in any particular order.

In-Vitro Lung ModelMarket News and Recent Developments

The In-Vitro Lung ModelMarket is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in them market for In-Vitro Lung Model and strategies:

• In December 2021, Lonza announced collaboration with Agilent Technologies Inc. and development of innovative analytical technologies with "Lonza's Cocoon Platform". The partnership seeks to advance the incorporation of existing and novel analytical methods to manufacture workflow of patient-scale cell therapies using the Cocoon Platform. Therefore, companies through collaboration will move forward in creating sustainable technologies and solutions enhancing the availability of crucial cell-based therapies for diverse lung disease.

In-Vitro Lung ModelMarket Report Coverage and Deliverables

The “In-Vitro Lung ModelMarket Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles